| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Moelis & Company's insiders have reduced their positions by a net 1,881 shares worth roughly $130K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 236.9K | $14.54M | - | |
| Other | 209.3K | $12.84M | - | |
| COO | 8.0K | $488.9K | - | |
| CFO | 2.3K | $140.6K | - | |
| Dir | 1.8K | $110.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2018 | Navid Mahmoodzadegan48 | MD & Co-president | Sell | 33,468 | $51.42 | $1,720,870.35 | -100% | |
| Mar 1, 2018 | Jeffrey Raich51 | MD & Co-president | Sell | 33,468 | $51.42 | $1,720,798.26 | -100% | |
| Feb 27, 2018 | J Richard Leaman III | MD & Vice Chairman | Sell | 10,568 | $51.47 | $543,902.20 | -100% | |
| Feb 26, 2018 | Jeffrey Raich51 | MD & Co-president | Sale+OE | 53,470 | $50.28 | $2,688,400.00 | -61.5% | |
| Feb 26, 2018 | Navid Mahmoodzadegan48 | MD & Co-president | Sale+OE | 53,470 | $50.28 | $2,688,400.00 | -61.5% | |
| Feb 26, 2018 | Elizabeth Crain63 | Chief Operating Officer | Sale+OE | 17,164 | $50.66 | $869,465.99 | - | |
| Feb 26, 2018 | J Richard Leaman III | MD & Vice Chairman | Sale+OE | 20,572 | $50.33 | $1,035,324.40 | -66.1% | |
| Feb 23, 2018 | Christopher Callesano48 | Ed & Principal Acct Officer | Sale+OE | 1,360 | $50.51 | $68,693.60 | - | |
| Feb 23, 2018 | Joseph Simon | Chief Financial Officer | Sale+OE | 10,202 | $50.76 | $517,823.88 | - | |
| Feb 22, 2018 | Kenneth Moelis56 | Chairman and CEO | Sale+OE | 49,116 | $50.00 | $2,455,800.00 | -50.0% |